New Delhi, Apr 7 Sun Pharmaceutical Industries will fully acquire troubled Ranbaxy Laboratories, in an all-stock transaction with a total equity value of USD 3.2 billion.
“Sun Pharmaceutical Industries Ltd and Ranbaxy Laboratories Ltd today announced that they have entered into definitive agreements pursuant to which Sun Pharma will acquire 100 per cent of Ranbaxy in an all-stock transaction,” the two companies said in a statement.
Under these agreements, Ranbaxy shareholders will receive 0.
000 25 30 50 2016 Bangalore Bangalore’s Biggest business China commentary CREDAI Bengaluru economy elections entertainment events extreme featured health heart disease How your stressful job may kill you?? India India's first upgraded MiG-29UPG fighter aircraft has begun scheduled flights Indian Terrain Tour of Nilgiris 2015 concludes at Pollachi Japan lifestyle Mentor Conclave 2015 Most-Awaited In-Mall Fashion Extravaganza is back Narendra Modi news New study Now politics Pomegranates have been found to have no effect on most heart risk factors QNET Hosts National Para Badminton Championship 2015 Continues its drive for Sports Russia Saketh-Sanam clinch doubles crown Secretary sharad pawar Shraddha Kapoor Sonakshi Sinha Sport Supreme Court Talent is less important than passion when it comes to professional success Tamil Nadu trains delayed
